207 related articles for article (PubMed ID: 21296175)
21. HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: Detection by qualitative multiplex PCR and subsequent quantitative real-time PCR.
Inazawa N; Hori T; Yamamoto M; Hatakeyama N; Yoto Y; Nojima M; Yasui H; Suzuki N; Shimizu N; Tsutsumi H
J Med Virol; 2016 Feb; 88(2):319-23. PubMed ID: 26241219
[TBL] [Abstract][Full Text] [Related]
22. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
[TBL] [Abstract][Full Text] [Related]
23. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
24. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
Ogata M; Satou T; Inoue Y; Takano K; Ikebe T; Ando T; Ikewaki J; Kohno K; Nishida A; Saburi M; Miyazaki Y; Ohtsuka E; Saburi Y; Fukuda T; Kadota J
Bone Marrow Transplant; 2013 Feb; 48(2):257-64. PubMed ID: 22750998
[TBL] [Abstract][Full Text] [Related]
25. Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation.
Kamble RT; Clark DA; Leong HN; Heslop HE; Brenner MK; Carrum G
Bone Marrow Transplant; 2007 Sep; 40(6):563-6. PubMed ID: 17637686
[TBL] [Abstract][Full Text] [Related]
26. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.
Schlenk RF; Döhner K; Mack S; Stoppel M; Király F; Götze K; Hartmann F; Horst HA; Koller E; Petzer A; Grimminger W; Kobbe G; Glasmacher A; Salwender H; Kirchen H; Haase D; Kremers S; Matzdorff A; Benner A; Döhner H
J Clin Oncol; 2010 Oct; 28(30):4642-8. PubMed ID: 20805454
[TBL] [Abstract][Full Text] [Related]
27. [Epileptic encephalopathy associated with human herpes virus 6 (HHV-6) encephalitis after the second cord blood transplantation in a patient with pediatric acute lymphoblastic leukemia].
Kouzuki K; Kato I; Kato T; Daifu T; Saida S; Umeda K; Hiramatsu H; Watanabe K; Ide M; Yoshida T; Imamura T; Ito K; Heike T; Adachi S
Rinsho Ketsueki; 2014 Dec; 55(12):2418-22. PubMed ID: 25744043
[TBL] [Abstract][Full Text] [Related]
28. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.
Ogata M; Kikuchi H; Satou T; Kawano R; Ikewaki J; Kohno K; Kashima K; Ohtsuka E; Kadota J
J Infect Dis; 2006 Jan; 193(1):68-79. PubMed ID: 16323134
[TBL] [Abstract][Full Text] [Related]
29. Human herpesvirus-6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis.
Miura H; Kawamura Y; Hattori F; Tanaka M; Kudo K; Ihira M; Yatsuya H; Takahashi Y; Kojima S; Sakaguchi H; Yoshida N; Hama A; Yoshikawa T
Transpl Infect Dis; 2020 Feb; 22(1):e13203. PubMed ID: 31650671
[TBL] [Abstract][Full Text] [Related]
30. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
31. [Human herpesvirus-6 associated with hematopoietic stem cell transplantation].
Ogata M
Rinsho Ketsueki; 2015 Oct; 56(10):2160-9. PubMed ID: 26458456
[TBL] [Abstract][Full Text] [Related]
32. Human herpesvirus-6 and -7 in pediatric stem cell transplantation.
Savolainen H; Lautenschlager I; Piiparinen H; Saarinen-Pihkala U; Hovi L; Vettenranta K
Pediatr Blood Cancer; 2005 Nov; 45(6):820-5. PubMed ID: 15700258
[TBL] [Abstract][Full Text] [Related]
33. Correlations of cytokine levels in cerebrospinal fluid and peripheral blood with outcome of HHV-6B encephalitis after hematopoietic stem cell transplantation.
Takano K; Ogata M; Satou T; Miyazaki Y; Otsuka E; Saito N; Ueki T; Kako S; Fukuda T; Shirao K
Transpl Infect Dis; 2019 Dec; 21(6):e13172. PubMed ID: 31520510
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation.
Ogata M; Oshima K; Ikebe T; Takano K; Kanamori H; Kondo T; Ueda Y; Mori T; Hashimoto H; Ogawa H; Eto T; Ueki T; Miyamoto T; Ichinohe T; Atsuta Y; Fukuda T
Bone Marrow Transplant; 2017 Nov; 52(11):1563-1570. PubMed ID: 28783148
[TBL] [Abstract][Full Text] [Related]
35. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
[TBL] [Abstract][Full Text] [Related]
36. Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.
Boehm A; Walcherberger B; Sperr WR; Wöhrer S; Dieckmann K; Rosenmayr A; Pernicka E; Fischer G; Worel N; Mitterbauer G; Schwarzinger I; Mitterbauer M; Haas OA; Lechner K; Hinterberger W; Valent P; Greinix HT; Rabitsch W; Kalhs P
Biol Blood Marrow Transplant; 2011 Jan; 17(1):133-40. PubMed ID: 20601032
[TBL] [Abstract][Full Text] [Related]
37. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
Hill JA; Koo S; Guzman Suarez BB; Ho VT; Cutler C; Koreth J; Armand P; Alyea EP; Baden LR; Antin JH; Soiffer RJ; Marty FM
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1638-48. PubMed ID: 22564265
[TBL] [Abstract][Full Text] [Related]
38. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001).
Safdar A; Singhal S; Mehta J
Cancer; 2004 Jun; 100(11):2456-61. PubMed ID: 15160352
[TBL] [Abstract][Full Text] [Related]
40. Posterior reversible encephalopathy syndrome concurrent with human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation.
Ito Y; Toyama K; Honda A; Nakazaki K; Arai S; Kurokawa M
J Infect Chemother; 2020 Feb; 26(2):265-268. PubMed ID: 31421950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]